The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Advanced Pharmaceutical Intermediates Market Research Report 2025
Synopsis
Advanced pharmaceutical intermediates play a crucial role in the pharmaceutical industry as essential building blocks in the synthesis of active pharmaceutical ingredients (APIs) and final drug products. These intermediates are complex chemical compounds that undergo further chemical reactions to produce the desired APIs. The market for advanced pharmaceutical intermediates is driven by the increasing demand for innovative and effective drugs to treat various medical conditions.
Global Advanced Pharmaceutical Intermediates market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Advanced Pharmaceutical Intermediates market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Advanced Pharmaceutical Intermediates market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
BASF
Lonza
Divi's Laboratories
ZCL Chemicals
Jubilant
Shree Ganesh Remedies Limited
Borregaard
Porton Fine Chemicals
Lianhe Chemical Technology
ABA Chem
Suzhou Tianma Pharma Group
Yongtai Technology
Heryi Pharmaceutical
Segment by Type
Non-GMP intermediate
GMP intermediate
Segment by Application
Antibiotics
Antipyretic and Analgesic
Cardiovascular System
Anti-Cancer
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Advanced Pharmaceutical Intermediates report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Advanced pharmaceutical intermediates play a crucial role in the pharmaceutical industry as essential building blocks in the synthesis of active pharmaceutical ingredients (APIs) and final drug products. These intermediates are complex chemical compounds that undergo further chemical reactions to produce the desired APIs. The market for advanced pharmaceutical intermediates is driven by the increasing demand for innovative and effective drugs to treat various medical conditions.
Global Advanced Pharmaceutical Intermediates market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Advanced Pharmaceutical Intermediates market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Advanced Pharmaceutical Intermediates market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
BASF
Lonza
Divi's Laboratories
ZCL Chemicals
Jubilant
Shree Ganesh Remedies Limited
Borregaard
Porton Fine Chemicals
Lianhe Chemical Technology
ABA Chem
Suzhou Tianma Pharma Group
Yongtai Technology
Heryi Pharmaceutical
Segment by Type
Non-GMP intermediate
GMP intermediate
Segment by Application
Antibiotics
Antipyretic and Analgesic
Cardiovascular System
Anti-Cancer
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Advanced Pharmaceutical Intermediates report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Advanced Pharmaceutical Intermediates Market Overview
1.1 Product Overview and Scope of Advanced Pharmaceutical Intermediates
1.2 Advanced Pharmaceutical Intermediates Segment by Type
1.2.1 Global Advanced Pharmaceutical Intermediates Market Value Comparison by Type (2023-2029)
1.2.2 Non-GMP intermediate
1.2.3 GMP intermediate
1.3 Advanced Pharmaceutical Intermediates Segment by Application
1.3.1 Global Advanced Pharmaceutical Intermediates Market Value by Application: (2023-2029)
1.3.2 Antibiotics
1.3.3 Antipyretic and Analgesic
1.3.4 Cardiovascular System
1.3.5 Anti-Cancer
1.3.6 Others
1.4 Global Advanced Pharmaceutical Intermediates Market Size Estimates and Forecasts
1.4.1 Global Advanced Pharmaceutical Intermediates Revenue 2018-2029
1.4.2 Global Advanced Pharmaceutical Intermediates Sales 2018-2029
1.4.3 Global Advanced Pharmaceutical Intermediates Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Advanced Pharmaceutical Intermediates Market Competition by Manufacturers
2.1 Global Advanced Pharmaceutical Intermediates Sales Market Share by Manufacturers (2018-2023)
2.2 Global Advanced Pharmaceutical Intermediates Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Advanced Pharmaceutical Intermediates Average Price by Manufacturers (2018-2023)
2.4 Global Advanced Pharmaceutical Intermediates Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Advanced Pharmaceutical Intermediates, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Advanced Pharmaceutical Intermediates, Product Type & Application
2.7 Advanced Pharmaceutical Intermediates Market Competitive Situation and Trends
2.7.1 Advanced Pharmaceutical Intermediates Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Advanced Pharmaceutical Intermediates Players Market Share by Revenue
2.7.3 Global Advanced Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Advanced Pharmaceutical Intermediates Retrospective Market Scenario by Region
3.1 Global Advanced Pharmaceutical Intermediates Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Advanced Pharmaceutical Intermediates Global Advanced Pharmaceutical Intermediates Sales by Region: 2018-2029
3.2.1 Global Advanced Pharmaceutical Intermediates Sales by Region: 2018-2023
3.2.2 Global Advanced Pharmaceutical Intermediates Sales by Region: 2024-2029
3.3 Global Advanced Pharmaceutical Intermediates Global Advanced Pharmaceutical Intermediates Revenue by Region: 2018-2029
3.3.1 Global Advanced Pharmaceutical Intermediates Revenue by Region: 2018-2023
3.3.2 Global Advanced Pharmaceutical Intermediates Revenue by Region: 2024-2029
3.4 North America Advanced Pharmaceutical Intermediates Market Facts & Figures by Country
3.4.1 North America Advanced Pharmaceutical Intermediates Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Advanced Pharmaceutical Intermediates Sales by Country (2018-2029)
3.4.3 North America Advanced Pharmaceutical Intermediates Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Advanced Pharmaceutical Intermediates Market Facts & Figures by Country
3.5.1 Europe Advanced Pharmaceutical Intermediates Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Advanced Pharmaceutical Intermediates Sales by Country (2018-2029)
3.5.3 Europe Advanced Pharmaceutical Intermediates Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Advanced Pharmaceutical Intermediates Market Facts & Figures by Country
3.6.1 Asia Pacific Advanced Pharmaceutical Intermediates Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Advanced Pharmaceutical Intermediates Sales by Country (2018-2029)
3.6.3 Asia Pacific Advanced Pharmaceutical Intermediates Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Advanced Pharmaceutical Intermediates Market Facts & Figures by Country
3.7.1 Latin America Advanced Pharmaceutical Intermediates Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Advanced Pharmaceutical Intermediates Sales by Country (2018-2029)
3.7.3 Latin America Advanced Pharmaceutical Intermediates Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Advanced Pharmaceutical Intermediates Market Facts & Figures by Country
3.8.1 Middle East and Africa Advanced Pharmaceutical Intermediates Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Advanced Pharmaceutical Intermediates Sales by Country (2018-2029)
3.8.3 Middle East and Africa Advanced Pharmaceutical Intermediates Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Advanced Pharmaceutical Intermediates Sales by Type (2018-2029)
4.1.1 Global Advanced Pharmaceutical Intermediates Sales by Type (2018-2023)
4.1.2 Global Advanced Pharmaceutical Intermediates Sales by Type (2024-2029)
4.1.3 Global Advanced Pharmaceutical Intermediates Sales Market Share by Type (2018-2029)
4.2 Global Advanced Pharmaceutical Intermediates Revenue by Type (2018-2029)
4.2.1 Global Advanced Pharmaceutical Intermediates Revenue by Type (2018-2023)
4.2.2 Global Advanced Pharmaceutical Intermediates Revenue by Type (2024-2029)
4.2.3 Global Advanced Pharmaceutical Intermediates Revenue Market Share by Type (2018-2029)
4.3 Global Advanced Pharmaceutical Intermediates Price by Type (2018-2029)
5 Segment by Application
5.1 Global Advanced Pharmaceutical Intermediates Sales by Application (2018-2029)
5.1.1 Global Advanced Pharmaceutical Intermediates Sales by Application (2018-2023)
5.1.2 Global Advanced Pharmaceutical Intermediates Sales by Application (2024-2029)
5.1.3 Global Advanced Pharmaceutical Intermediates Sales Market Share by Application (2018-2029)
5.2 Global Advanced Pharmaceutical Intermediates Revenue by Application (2018-2029)
5.2.1 Global Advanced Pharmaceutical Intermediates Revenue by Application (2018-2023)
5.2.2 Global Advanced Pharmaceutical Intermediates Revenue by Application (2024-2029)
5.2.3 Global Advanced Pharmaceutical Intermediates Revenue Market Share by Application (2018-2029)
5.3 Global Advanced Pharmaceutical Intermediates Price by Application (2018-2029)
6 Key Companies Profiled
6.1 BASF
6.1.1 BASF Corporation Information
6.1.2 BASF Description and Business Overview
6.1.3 BASF Advanced Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2023)
6.1.4 BASF Advanced Pharmaceutical Intermediates Product Portfolio
6.1.5 BASF Recent Developments/Updates
6.2 Lonza
6.2.1 Lonza Corporation Information
6.2.2 Lonza Description and Business Overview
6.2.3 Lonza Advanced Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Lonza Advanced Pharmaceutical Intermediates Product Portfolio
6.2.5 Lonza Recent Developments/Updates
6.3 Divi's Laboratories
6.3.1 Divi's Laboratories Corporation Information
6.3.2 Divi's Laboratories Description and Business Overview
6.3.3 Divi's Laboratories Advanced Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Divi's Laboratories Advanced Pharmaceutical Intermediates Product Portfolio
6.3.5 Divi's Laboratories Recent Developments/Updates
6.4 ZCL Chemicals
6.4.1 ZCL Chemicals Corporation Information
6.4.2 ZCL Chemicals Description and Business Overview
6.4.3 ZCL Chemicals Advanced Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2023)
6.4.4 ZCL Chemicals Advanced Pharmaceutical Intermediates Product Portfolio
6.4.5 ZCL Chemicals Recent Developments/Updates
6.5 Jubilant
6.5.1 Jubilant Corporation Information
6.5.2 Jubilant Description and Business Overview
6.5.3 Jubilant Advanced Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Jubilant Advanced Pharmaceutical Intermediates Product Portfolio
6.5.5 Jubilant Recent Developments/Updates
6.6 Shree Ganesh Remedies Limited
6.6.1 Shree Ganesh Remedies Limited Corporation Information
6.6.2 Shree Ganesh Remedies Limited Description and Business Overview
6.6.3 Shree Ganesh Remedies Limited Advanced Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Shree Ganesh Remedies Limited Advanced Pharmaceutical Intermediates Product Portfolio
6.6.5 Shree Ganesh Remedies Limited Recent Developments/Updates
6.7 Borregaard
6.6.1 Borregaard Corporation Information
6.6.2 Borregaard Description and Business Overview
6.6.3 Borregaard Advanced Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Borregaard Advanced Pharmaceutical Intermediates Product Portfolio
6.7.5 Borregaard Recent Developments/Updates
6.8 Porton Fine Chemicals
6.8.1 Porton Fine Chemicals Corporation Information
6.8.2 Porton Fine Chemicals Description and Business Overview
6.8.3 Porton Fine Chemicals Advanced Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Porton Fine Chemicals Advanced Pharmaceutical Intermediates Product Portfolio
6.8.5 Porton Fine Chemicals Recent Developments/Updates
6.9 Lianhe Chemical Technology
6.9.1 Lianhe Chemical Technology Corporation Information
6.9.2 Lianhe Chemical Technology Description and Business Overview
6.9.3 Lianhe Chemical Technology Advanced Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Lianhe Chemical Technology Advanced Pharmaceutical Intermediates Product Portfolio
6.9.5 Lianhe Chemical Technology Recent Developments/Updates
6.10 ABA Chem
6.10.1 ABA Chem Corporation Information
6.10.2 ABA Chem Description and Business Overview
6.10.3 ABA Chem Advanced Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2023)
6.10.4 ABA Chem Advanced Pharmaceutical Intermediates Product Portfolio
6.10.5 ABA Chem Recent Developments/Updates
6.11 Suzhou Tianma Pharma Group
6.11.1 Suzhou Tianma Pharma Group Corporation Information
6.11.2 Suzhou Tianma Pharma Group Advanced Pharmaceutical Intermediates Description and Business Overview
6.11.3 Suzhou Tianma Pharma Group Advanced Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Suzhou Tianma Pharma Group Advanced Pharmaceutical Intermediates Product Portfolio
6.11.5 Suzhou Tianma Pharma Group Recent Developments/Updates
6.12 Yongtai Technology
6.12.1 Yongtai Technology Corporation Information
6.12.2 Yongtai Technology Advanced Pharmaceutical Intermediates Description and Business Overview
6.12.3 Yongtai Technology Advanced Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Yongtai Technology Advanced Pharmaceutical Intermediates Product Portfolio
6.12.5 Yongtai Technology Recent Developments/Updates
6.13 Heryi Pharmaceutical
6.13.1 Heryi Pharmaceutical Corporation Information
6.13.2 Heryi Pharmaceutical Advanced Pharmaceutical Intermediates Description and Business Overview
6.13.3 Heryi Pharmaceutical Advanced Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Heryi Pharmaceutical Advanced Pharmaceutical Intermediates Product Portfolio
6.13.5 Heryi Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Advanced Pharmaceutical Intermediates Industry Chain Analysis
7.2 Advanced Pharmaceutical Intermediates Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Advanced Pharmaceutical Intermediates Production Mode & Process
7.4 Advanced Pharmaceutical Intermediates Sales and Marketing
7.4.1 Advanced Pharmaceutical Intermediates Sales Channels
7.4.2 Advanced Pharmaceutical Intermediates Distributors
7.5 Advanced Pharmaceutical Intermediates Customers
8 Advanced Pharmaceutical Intermediates Market Dynamics
8.1 Advanced Pharmaceutical Intermediates Industry Trends
8.2 Advanced Pharmaceutical Intermediates Market Drivers
8.3 Advanced Pharmaceutical Intermediates Market Challenges
8.4 Advanced Pharmaceutical Intermediates Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
